42 related articles for article (PubMed ID: 11883334)
1. Serum oestradiol in women with carcinomas of the breast and uterine cervix.
Ray A; Bahadur AK; Dayalu Naik SL; Sharma BK
Indian J Clin Biochem; 2001 Jul; 16(2):199-202. PubMed ID: 23105318
[TBL] [Abstract][Full Text] [Related]
2. Bazedoxifene activates the angiotensin II-induced HUVEC hypertension model by targeting SIRT1.
Yu Q; Zhao J; Liu B
Exp Ther Med; 2022 Feb; 23(2):120. PubMed ID: 34970343
[TBL] [Abstract][Full Text] [Related]
3. Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole.
Bell LN; Nguyen AT; Li L; Desta Z; Henry NL; Hayes DF; Wolff AC; Stearns V; Storniolo AM; Flockhart DA;
J Clin Pharmacol; 2012 Dec; 52(12):1852-60. PubMed ID: 22174434
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen.
Ntukidem NI; Nguyen AT; Stearns V; Rehman M; Schott A; Skaar T; Jin Y; Blanche P; Li L; Lemler S; Hayden J; Krauss RM; Desta Z; Flockhart DA; Hayes DF;
Clin Pharmacol Ther; 2008 May; 83(5):702-10. PubMed ID: 17713466
[TBL] [Abstract][Full Text] [Related]
5. A comparative of the effect of tamoxifen on serum lipid and lipoprotein profile in premenopausal & postmenopausal women with breast carcinoma & associated risk of vascular complication.
Sharma D; Sharma U; Bhatnagar VB; Singh VS
Indian J Med Sci; 2001 Jan; 55(1):37-42. PubMed ID: 11480395
[TBL] [Abstract][Full Text] [Related]
6. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.
Ilanchezhian S; Thangaraju M; Sachdanandam P
Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439
[TBL] [Abstract][Full Text] [Related]
7. The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'.
Atalay G; Dirix L; Biganzoli L; Beex L; Nooij M; Cameron D; Lohrisch C; Cufer T; Lobelle JP; Mattiaci MR; Piccart M; Paridaens R
Ann Oncol; 2004 Feb; 15(2):211-7. PubMed ID: 14760111
[TBL] [Abstract][Full Text] [Related]
8. Effect of tamoxifen on plasma lipids and lipoproteins in postmenopausal women with breast cancer.
Thangaraju M; Kumar K; Gandhirajan R; Sachdanandam P
Cancer; 1994 Feb; 73(3):659-63. PubMed ID: 8299087
[TBL] [Abstract][Full Text] [Related]
9. Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy.
Dnistrian AM; Schwartz MK; Greenberg EJ; Smith CA; Schwartz DC
Clin Chim Acta; 1993 Dec; 223(1-2):43-52. PubMed ID: 8143369
[TBL] [Abstract][Full Text] [Related]
10. A study of the effect of tamoxifen on serum lipoprotein profiles in premenopausal and postmenopausal women with breast carcinoma and associated risk of cardiovascular disease.
Sharma D; Sharma U; Bhatnagar VB; Singh VS
Indian J Med Sci; 2001 Jul; 55(7):359-65. PubMed ID: 11883334
[TBL] [Abstract][Full Text] [Related]
11. Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
Esteva FJ; Hortobagyi GN
Breast; 2006 Jun; 15(3):301-12. PubMed ID: 16230014
[TBL] [Abstract][Full Text] [Related]
12. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
Jahanzeb M
Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
